NOD2 activation induces muscle cell-autonomous innate immune responses and insulin resistance.

Insulin resistance is associated with chronic low-grade inflammation in vivo, largely mediated by activated innate immune cells. Cytokines and pathogen-derived ligands of surface toll-like receptors can directly cause insulin resistance in muscle cells. However, it is not known if intracellular pathogen sensors can, on their own, provoke insulin resistance. Here, we show that the cytosolic pattern recognition receptors nucleotide-binding oligomerization domain-containing protein (NOD)1 and NOD2 are expressed in immune and metabolic tissues and hypothesize that their activation in muscle cells would result in cell-autonomous responses leading to insulin resistance. Bacterial peptidoglycan motifs that selectively activate NOD2 were directly administered to L6- GLUT4myc myotubes in culture. Within 3 h, insulin resistance arose, characterized by reductions in each insulin-stimulated glucose uptake, GLUT4 translocation, Akt Ser(473) phosphorylation, and insulin receptor substrate 1 tyrosine phosphorylation. Muscle cell-autonomous responses to NOD2 ligand included activation of the stress/inflammation markers c-Jun N-terminal kinase, ERK1/2, p38 MAPK, degradation of inhibitor of κBα, and production of proinflammatory cytokines. These results show that NOD2 alone is capable of acutely inducing insulin resistance within muscle cells, possibly by activating endogenous inflammatory signals and/or through cytokine production, curbing upstream insulin signals. NOD2 is hence a new inflammation target connected to insulin resistance, and this link occurs without the need of additional contributing cell types. This study provides supporting evidence for the integration of innate immune and metabolic responses through the involvement of NOD proteins and suggests the possible participation of cell autonomous immune responses in the development of insulin resistance in skeletal muscle, the major depot for postprandial glucose utilization.

[1]  Sabine Borwege,et al.  Nutrient Modification of the Innate Immune Response: A Novel Mechanism by Which Saturated Fatty Acids Greatly Amplify Monocyte Inflammation , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[2]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[3]  Kate Schroder,et al.  The NLRP3 Inflammasome: A Sensor for Metabolic Danger? , 2010, Science.

[4]  J. Tanti,et al.  Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. , 2009, Current opinion in pharmacology.

[5]  C. Peterson,et al.  Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. , 2009, American journal of physiology. Endocrinology and metabolism.

[6]  D. Piomelli Responses to stress: from the periphery to the brain. , 2009, Current opinion in pharmacology.

[7]  Masato Kasuga,et al.  [Obesity and insulin resistance]. , 2009, Nihon rinsho. Japanese journal of clinical medicine.

[8]  Jianping Ye,et al.  S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-α Signaling through IKK2* , 2008, Journal of Biological Chemistry.

[9]  A. Mora,et al.  A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance , 2008, Science.

[10]  J. Hartwig,et al.  GLUT4 Vesicle Recruitment and Fusion Are Differentially Regulated by Rac, AS160, and Rab8A in Muscle Cells* , 2008, Journal of Biological Chemistry.

[11]  A. Klip,et al.  Muscle cells engage Rab8A and myosin Vb in insulin-dependent GLUT4 translocation. , 2008, American journal of physiology. Cell physiology.

[12]  J. Olefsky,et al.  Insulin sensitivity: modulation by nutrients and inflammation. , 2008, The Journal of clinical investigation.

[13]  S. Girardin,et al.  Nucleotide Oligomerization Domains 1 and 2: Regulation of Expression and Function in Preadipocytes1 , 2008, The Journal of Immunology.

[14]  J. Zierath,et al.  siRNA-Mediated Reduction of Inhibitor of Nuclear Factor-κB Kinase Prevents Tumor Necrosis Factor-α–Induced Insulin Resistance in Human Skeletal Muscle , 2008, Diabetes.

[15]  V. Randhawa,et al.  Insulin action on glucose transporters through molecular switches, tracks and tethers. , 2008, The Biochemical journal.

[16]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[17]  H. Tilg,et al.  Inflammatory Mechanisms in the Regulation of Insulin Resistance , 2008, Molecular medicine.

[18]  Hui-yu Liu,et al.  Regulation of Interleukin-6-induced Hepatic Insulin Resistance by Mammalian Target of Rapamycin through the STAT3-SOCS3 Pathway* , 2008, Journal of Biological Chemistry.

[19]  J. Ninomiya-Tsuji,et al.  TAK1 Is a Central Mediator of NOD2 Signaling in Epidermal Cells* , 2008, Journal of Biological Chemistry.

[20]  S. Girardin,et al.  Nod1 and Nod2 in innate immunity and human inflammatory disorders. , 2007, Biochemical Society transactions.

[21]  C. Glass,et al.  A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways* , 2007, Journal of Biological Chemistry.

[22]  D. Philpott,et al.  Nod1 and Nod2 induce CCL5/RANTES through the NF‐κB pathway , 2007 .

[23]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[24]  G. Núñez,et al.  Nod1/RICK and TLR Signaling Regulate Chemokine and Antimicrobial Innate Immune Responses in Mesothelial Cells1 , 2007, The Journal of Immunology.

[25]  K. Fukase,et al.  Differential Modulation of Nods Signaling Pathways by Fatty Acids in Human Colonic Epithelial HCT116 Cells* , 2007, Journal of Biological Chemistry.

[26]  R. Ulevitch,et al.  SGT1 is essential for Nod1 activation , 2007, Proceedings of the National Academy of Sciences.

[27]  M. Czech,et al.  The GLUT4 glucose transporter. , 2007, Cell metabolism.

[28]  A. Rudich,et al.  Ceramide- and Oxidant-Induced Insulin Resistance Involve Loss of Insulin-Dependent Rac-Activation and Actin Remodeling in Muscle Cells , 2007, Diabetes.

[29]  F. Thong,et al.  The Rab GTPase-Activating Protein AS160 Integrates Akt, Protein Kinase C, and AMP-Activated Protein Kinase Signals Regulating GLUT4 Traffic , 2007, Diabetes.

[30]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[31]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[32]  M. Karin,et al.  Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates , 2006, Proceedings of the National Academy of Sciences.

[33]  J. Senn Toll-like Receptor-2 Is Essential for the Development of Palmitate-induced Insulin Resistance in Myotubes* , 2006, Journal of Biological Chemistry.

[34]  P. Reaven,et al.  Molecular and signaling mechanisms of atherosclerosis in insulin resistance. , 2006, Endocrinology and metabolism clinics of North America.

[35]  J. Eckel,et al.  Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. , 2006, Endocrinology.

[36]  D. Goeddel,et al.  NF-κB-Inducing Kinase Regulates Selected Gene Expression in the Nod2 Signaling Pathway , 2006, Infection and Immunity.

[37]  K. Petersen,et al.  New Insights into the Pathogenesis of Insulin Resistance in Humans Using Magnetic Resonance Spectroscopy , 2006, Obesity.

[38]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[39]  M. Chamaillard,et al.  NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. , 2005, Annual review of biochemistry.

[40]  Xudong Huang,et al.  Differential Contribution of Insulin Receptor Substrates 1 Versus 2 to Insulin Signaling and Glucose Uptake in L6 Myotubes* , 2005, Journal of Biological Chemistry.

[41]  M. Abreu,et al.  TLR Signaling in the Gut in Health and Disease1 , 2005, The Journal of Immunology.

[42]  C. Dani,et al.  The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. , 2005, Diabetes.

[43]  L. Cantley,et al.  The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO , 2004, Current Biology.

[44]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[45]  R. O’Doherty,et al.  Fatty Acid-induced Insulin Resistance in L6 Myotubes Is Prevented by Inhibition of Activation and Nuclear Localization of Nuclear Factor κB* , 2004, Journal of Biological Chemistry.

[46]  J. Pickup Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. , 2004, Diabetes care.

[47]  Xudong Huang,et al.  Skeletal muscle cells and adipocytes differ in their reliance on TC10 and Rac for insulin-induced actin remodeling. , 2004, Molecular endocrinology.

[48]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[49]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[50]  U. Smith,et al.  Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects* , 2003, Journal of Biological Chemistry.

[51]  J. Tanti,et al.  MAP kinases and mTOR mediate insulin-induced phosphorylation of Insulin Receptor Substrate-1 on serine residues 307, 612 and 632 , 2003, Diabetologia.

[52]  S. Foster,et al.  An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid , 2003, Nature Immunology.

[53]  H. Koistinen,et al.  5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. , 2003, Diabetes.

[54]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[55]  R. Garg,et al.  Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues , 2003, Diabetologia.

[56]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[57]  Richard J Sciotti,et al.  Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. , 2003, Diabetes.

[58]  D. Hwang,et al.  Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. , 2003, Journal of lipid research.

[59]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[60]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[61]  Yasunori Ogura,et al.  Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation* , 2002, The Journal of Biological Chemistry.

[62]  C. Lang,et al.  Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[63]  A. Marette Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings , 2002, Current opinion in clinical nutrition and metabolic care.

[64]  P. Hruz,et al.  Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations , 2002, AIDS.

[65]  Y. Zick Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. , 2001, Trends in cell biology.

[66]  J. Bertin,et al.  CARD4/Nod1 mediates NF‐κB and JNK activation by invasive Shigella flexneri , 2001 .

[67]  M. Quon,et al.  Tyr612 and Tyr632 in Human Insulin Receptor Substrate-1 Are Important for Full Activation of Insulin-Stimulated Phosphatidylinositol 3-Kinase Activity and Translocation of GLUT4 in Adipose Cells. , 2001, Endocrinology.

[68]  S. Yamaoka,et al.  Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.

[69]  C. Janeway,et al.  The Toll receptor family and microbial recognition. , 2000, Trends in microbiology.

[70]  P. Lucas,et al.  An Induced Proximity Model for NF-κB Activation in the Nod1/RICK and RIP Signaling Pathways , 2000 .

[71]  Roger Davis,et al.  The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.

[72]  A. Klip,et al.  GLUT-4myc ectopic expression in L6 myoblasts generates a GLUT-4-specific pool conferring insulin sensitivity. , 1999, American journal of physiology. Endocrinology and metabolism.

[73]  R. Ulevitch,et al.  Recognition of gram-negative bacteria and endotoxin by the innate immune system. , 1999, Current opinion in immunology.

[74]  A. Klip,et al.  GLUT4 translocation by insulin in intact muscle cells: detection by a fast and quantitative assay , 1998, FEBS letters.

[75]  Y. Nakaya,et al.  Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. , 1998, Diabetes.

[76]  R. Roth,et al.  Modulation of Insulin Receptor Substrate-1 Tyrosine Phosphorylation and Function by Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.

[77]  A. Klip,et al.  Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM , 1996, Diabetologia.

[78]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[79]  Ling Zhao,et al.  Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids. , 2010, Nutrition reviews.

[80]  A. Klip,et al.  Palmitate- and lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells. , 2009, American journal of physiology. Endocrinology and metabolism.

[81]  M. Hung,et al.  IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance. , 2008, International journal of molecular medicine.

[82]  Y. Le Marchand-Brustel,et al.  Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. , 2005, Biochimie.

[83]  P. Lucas,et al.  An Induced Proximity Model for NF- κ B Activation in the Nod1/RICK and RIP Signaling Pathways , 2000 .

[84]  J. Tanti,et al.  Interleukin-1 (cid:1) -Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression , 2022 .